...
首页> 外文期刊>Sociedade Brasileira de Medicina Tropical. Revista >Risk-benefit assessment of Bacillus Calmette-Guérin vaccination, anti-phenolic glycolipid I serology, and Mitsuda test response: 10-year follow-up of household contacts of leprosy patients
【24h】

Risk-benefit assessment of Bacillus Calmette-Guérin vaccination, anti-phenolic glycolipid I serology, and Mitsuda test response: 10-year follow-up of household contacts of leprosy patients

机译:卡介苗接种,抗酚糖脂I血清学和三田试验结果的风险效益评估:麻风病人家庭接触者的10年随访

获取原文
           

摘要

INTRODUCTION: Despite multidrug therapy, leprosy remains a public health issue. The intradermal Bacillus Calmette-Gu??rin (BCG) vaccine, Mitsuda test (lepromin skin test), and anti-phenolic glycolipid I (PGL-I) serology are widely used in leprosy studies and have shown great epidemiological value.
机译:简介:尽管采取了多种药物疗法,但麻风病仍然是公共卫生问题。皮内芽孢杆菌卡介苗(BCG)疫苗,三田试验(lepromin皮肤试验)和抗酚糖脂I(PGL-1)血清学被广泛用于麻风研究,并显示出很大的流行病学价值。

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号